Clinical Trials List
2021-04-01 - 2029-09-13
Phase III
Not yet recruiting3
Recruiting4
ICD-10K74.4
Secondary biliary cirrhosis
ICD-10K75.81
Nonalcoholic steatohepatitis (NASH)
ICD-10K76.0
Fatty (change of) liver, not elsewhere classified
ICD-10K76.89
Other specified diseases of liver
ICD-10R16.2
Hepatomegaly with splenomegaly, not elsewhere classified
ICD-9571.8
Other chronic nonalcoholic liver disease
-
-
Trial Applicant
NOVO NORDISK PHARMA (TAIWAN) LTD.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/14
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Chin-Sung Kuo Division of Endocrinology
- 王苑貞 Digestive System Department
- 黃惠君 Digestive System Department
- I-Cheng Lee Digestive System Department
- 李癸汌 Digestive System Department
- 吳啟榮 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 邱彥程 Digestive System Department
- Chiu Hung Chiu Digestive System Department
- 簡世杰 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 李忠憲 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jee-Fu Huang Digestive System Department
- 謝明彥 Digestive System Department
- Chung-Feng Huang Digestive System Department
- Wan-Long Chuang Digestive System Department
- Chia-Yen Dai Digestive System Department
- 梁博程 Digestive System Department
- Ming-Lun Yeh Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊宏志 Digestive System Department
- Shih-Jer Hsu Digestive System Department
- 蘇東弘 Digestive System Department
- PEI-JER CHEN Digestive System Department
- 洪俊銘 Digestive System Department
- Jia-Horng Kao Digestive System Department
- 曾岱宗 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
35 participants
-
Global
1200 participants
